STAT

This brand-new advocacy group is an unapologetic defender of high drug prices

It’s not clear who funds this new advocacy group or when it officially launched, but it’s already clear which side of the drug pricing debate it’s on.

WASHINGTON — It’s less than a week old, but a shadowy new pharma advocacy group is already launching diatribes against advocates for lower drug prices, blasting pharmacy middlemen and defending even sky-high list prices for prescription drugs.

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readSociety
How Europe Is Building A Sweeping System To Study Medication Safety In Pregnant And Lactating Women
More than 88 organizations have joined a sweeping new effort in Europe to tackle the research gaps on medication use in pregnant and lactating women.
STAT4 min read
Alarmed By New ‘CRISPR Babies’ Plan, Top Science Figures Say They’re Powerless To Stop It
Outraged by a new plan to create "CRISPR babies" in Russia, leading science figures concede that their organizations are powerless to stop it.
STAT1 min read
Listen: A Controversial Desire Drug, Courtroom Genealogy, & The Quest For Longer Life
Is desire a matter of medicine? Can you convict on genealogy? And what do you get the alleged bride who has it all? We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, we discuss a new drug meant t